Patents by Inventor Zhanjuan Chen

Zhanjuan Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963519
    Abstract: The present disclosure provides a kit and method for constructing a long-acting depression animal model. The present disclosure adopts Bacille Calmette-Guerin (BCG) (or Mycobacterium bovis (M bovis)) and low-dose pertussis toxin (PTX) for combined induction, which greatly reduces modeling cost. A mouse model constructed by the method of the present disclosure can clearly distinguish a time interval of pathological behaviors from a time interval of depression-like behaviors and has prominent face validity and predictive validity. The method of the present disclosure is simple and convenient and does not require a large number of tedious daily operations as the depression model construction by chronic unpredictable stress, chronic restraint stress, social defeat, mother-child separation, or the like. The mouse model of the present disclosure can provide a valuable long-term intervention window for research on antidepressant therapy.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: April 23, 2024
    Assignee: Northwest Institute of Plateau Biology, CAS
    Inventors: Cen Li, Hongxia Yang, Jing Zhao, Lixin Wei, Yuzhi Du, Yuancan Xiao, Hongtao Bi, Zhanjuan Chen, Yajun Qiao, Jianv Wang
  • Publication number: 20230329200
    Abstract: The present disclosure provides a kit and method for constructing a long-acting depression animal model. The present disclosure adopts Bacille Calmette-Guerin (BCG) (or Mycobacterium bovis (M. bovis)) and low-dose pertussis toxin (PTX) for combined induction, which greatly reduces modeling cost. A mouse model constructed by the method of the present disclosure can clearly distinguish a time interval of pathological behaviors from a time interval of depression-like behaviors and has prominent face validity and predictive validity. The method of the present disclosure is simple and convenient and does not require a large number of tedious daily operations as the depression model construction by chronic unpredictable stress, chronic restraint stress, social defeat, mother-child separation, or the like. The mouse model of the present disclosure can provide a valuable long-term intervention window for research on antidepressant therapy.
    Type: Application
    Filed: August 25, 2022
    Publication date: October 19, 2023
    Applicant: Northwest Institute of Plateau Biology, CAS
    Inventors: Cen Li, Hongxia Yang, Jing Zhao, Lixin Wei, Yuzhi Du, Yuancan Xiao, Hongtao Bi, Zhanjuan Chen, Yajun Qiao, Jianv Wang